Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
7.
Acta Derm Venereol ; 98(1): 50-58, 2018 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-28853491

RESUMEN

Differential diagnosis of palmoplantar non-pustular psoriasis and chronic allergic contact dermatitis (ACD) and the combination of these conditions, termed "eczema in psoriatico" (EIP), is difficult, especially in cases of isolated involvement. A blind re-evaluation of 63 archived formalin-fixed palmoplantar samples, previously diagnosed clinically as either psoriasis or chronic ACD, was performed. Samples were allocated to histopathological diagnoses of psoriasis, contact dermatitis or EIP. Immunohistological stainings were performed for better characterization. Immunochemistry of EIP revealed features that overlapped contemporarily with psoriasis (cytokeratin 17 (CK17), Ki67, interleukin (IL)-8, IL-17, IL-23) and with ACD (CD1a, major histocompatibility complex (MHC) class I, MHC class II, epidermal T-cell subsets). Surprisingly, a significantly much higher number of dermal CD8+ T cells was found in EIP than in ACD and psoriasis. In conclusion, this study provides insight into the immunohistological differentiation of palmoplantar psoriasis, chronic ACD and EIP.


Asunto(s)
Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Alérgica por Contacto/metabolismo , Interleucinas/metabolismo , Psoriasis/diagnóstico , Psoriasis/metabolismo , Antígenos CD1/metabolismo , Linfocitos T CD8-positivos/patología , Enfermedad Crónica , Dermatitis Alérgica por Contacto/complicaciones , Dermatitis Alérgica por Contacto/patología , Diagnóstico Diferencial , Proteínas Filagrina , Antígenos de Histocompatibilidad Clase I/metabolismo , Antígenos de Histocompatibilidad Clase II/metabolismo , Humanos , Inmunoglobulina E/sangre , Inmunohistoquímica , Proteínas de Filamentos Intermediarios/metabolismo , Queratina-17/metabolismo , Antígeno Ki-67/metabolismo , Recuento de Linfocitos , Psoriasis/complicaciones , Psoriasis/patología , Subgrupos de Linfocitos T/patología
8.
J Voice ; 31(6): 763-772, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28461166

RESUMEN

OBJECTIVE/HYPOTHESIS: Talking is a significant trigger for cough in patients with chronic cough; however, the stimulus required to trigger cough has not been quantified. The aim of this study was to examine the effect of a vocal loading task on phonation and cough behavior in patients with chronic cough and identify change following therapy. STUDY DESIGN: This is a prospective observational study. METHODS: This study involved 33 patients with chronic cough. Participants were assessed with the lingWAVES Vocal Loading Test protocol before and after intervention for chronic cough. RESULTS: At baseline, almost 40% of patients had impaired vocal function and were unable to complete the vocal loading test. This improved following therapy, with 94% of patients being able to complete the test at follow-up. There was difficulty maintaining phonation, with 60% of the task unvoiced at baseline. This improved following therapy. The vocal loading test triggered coughing in 58% of patients; however, this improved following intervention. Acoustic measures during the vocal loading test did not change following therapy. CONCLUSION: Phonation is an important trigger for cough. Patients with chronic cough demonstrated impaired performance on tests of vocal loading. Most parameters improved following therapy.


Asunto(s)
Tos/fisiopatología , Laringe/fisiopatología , Fonación , Trastornos de la Voz/fisiopatología , Calidad de la Voz , Acústica , Anciano , Enfermedad Crónica , Tos/diagnóstico , Tos/tratamiento farmacológico , Femenino , Humanos , Laringe/efectos de los fármacos , Masculino , Persona de Mediana Edad , Pregabalina/uso terapéutico , Estudios Prospectivos , Ensayos Clínicos Controlados Aleatorios como Asunto , Espectrografía del Sonido , Acústica del Lenguaje , Medición de la Producción del Habla , Factores de Tiempo , Resultado del Tratamiento , Trastornos de la Voz/diagnóstico , Trastornos de la Voz/tratamiento farmacológico
9.
J Clin Invest ; 127(3): 912-928, 2017 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-28165339

RESUMEN

Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1Δ yeast strains, whereas expression of disease-associated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.


Asunto(s)
Aldehído-Liasas , Movimiento Celular/genética , Ictiosis Lamelar , Células Mesangiales/enzimología , Mutación , Síndrome Nefrótico , Aldehído-Liasas/genética , Aldehído-Liasas/metabolismo , Animales , Línea Celular , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila melanogaster , Femenino , Humanos , Ictiosis Lamelar/enzimología , Ictiosis Lamelar/genética , Ictiosis Lamelar/patología , Masculino , Células Mesangiales/patología , Ratones , Ratones Noqueados , Síndrome Nefrótico/enzimología , Síndrome Nefrótico/genética , Síndrome Nefrótico/patología , Transporte de Proteínas/genética , Ratas
11.
Ann Hematol ; 94(2): 283-7, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25138222

RESUMEN

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematodermic neoplasm which typically presents with skin infiltrates with or without lymphadenopathy and bone marrow involvement. No standard of care exists for this aggressive disease and prognosis is particularly poor. Here, we present our experience with nine BPDCN patients diagnosed at our institution between 2005 and 2012. BPDCN patients were identified in the databases at the Department of Hematology and Oncology, the Department of Dermatology, and the Institute of Pathology at the Otto-von-Guericke-University Magdeburg. There were six male and three female patients with a median age at diagnosis of 66 years. Sites involved were skin (five cases), lymph nodes (five cases), and bone marrow (five cases). Treatments varied from single agent chemotherapy to polychemotherapy and allogeneic stem cell transplantation for consolidation. The three patients that were treated with acute leukemia-type induction therapy followed by allogeneic stem cell transplantation (one after standard conditioning and two after reduced intensity conditioning using fludarabine in combination with thiotepa) achieved sustained remissions and are alive with a follow-up of 8, 35, and 41 months. In contrast, median survival in the less intensively treated patients was only 9.5 (range 1 to 29) months.


Asunto(s)
Células Dendríticas/patología , Neoplasias Hematológicas/terapia , Trasplante de Células Madre Hematopoyéticas/métodos , Neoplasias Cutáneas/terapia , Donante no Emparentado , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Quimioradioterapia/métodos , Terapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Inducción de Remisión , Estudios Retrospectivos , Análisis de Supervivencia , Trasplante Homólogo , Resultado del Tratamiento , Adulto Joven
13.
Acta Derm Venereol ; 94(5): 517-20, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24531394

RESUMEN

There is growing evidence that not only malign keratinocytic but also melanocytic tumours can arise during treatment with vemurafenib. During an on-going early access trial, 13 patients harbouring a BRAF-V600E mutation received vemurafenib (Zelboraf®) 960 mg twice daily to test the safety, tolerability, efficacy and response rate for advanced melanoma. Clinically or dermatoscopically suspicious cutaneous tumours under treatment with vemurafenib were excised. The BRAF-V600E status of confirmed new primary melanoma and dysplastic naevi was tested using a genetic mutation assay and immunohistochemistry. Four of the 13 patients (31%) developed 4 new naevi-associated malignant melanomas and 5 dysplastic naevi between 6 weeks and 6 months after the start of treatment. With the exception of one in situ melanoma, all tumours were BRAF wild-type. Immunohistochemistry revealed increased expression of ERK, pERK and active Rac1-GTP in the naevi-associated melanoma and dysplastic naevi. Careful and continuous skin examination, including dermoscopy, appears to be required during treatment with vemurafenib.


Asunto(s)
Antineoplásicos/efectos adversos , Síndrome del Nevo Displásico/patología , Indoles/efectos adversos , Melanoma/patología , Mutación , Proteínas Proto-Oncogénicas B-raf/genética , Neoplasias Cutáneas/patología , Sulfonamidas/efectos adversos , Adulto , Anciano , Neoplasias Encefálicas/secundario , Síndrome del Nevo Displásico/genética , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Genotipo , Humanos , Inmunohistoquímica , Neoplasias Pulmonares/secundario , Melanoma/tratamiento farmacológico , Melanoma/genética , Persona de Mediana Edad , Fragmentos de Péptidos/metabolismo , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/genética , Vemurafenib , Proteína de Unión al GTP rac1/metabolismo
18.
J Dtsch Dermatol Ges ; 9(6): 444-7, 2011 Jun.
Artículo en Inglés, Alemán | MEDLINE | ID: mdl-21166783

RESUMEN

Varicella has the highest contagiosity index of all viral diseases. We report an endemic outbreak of varicella among 4 Indian students in Magdeburg in November and December 2008. An initially severe course was observed in three of these patients with a negative vaccination status. Large vesicular skin lesions with a diameter of up to 8 mm were found in all patients. Molecular genetic tests revealed African/Indian clade 5 in 2 patients, although the European clades (i.e., clade 1 and 3) are the most common in Germany, accounting for 85 %. All patients recovered without any complications after administration of intravenous aciclovir at a dosage of 10 mg per kg body weight. Although isolated cases of varicella are not notifiable according to the German Protection against Infection Act, endemic outbreaks must be reported to the appropriate health surveillance authorities.


Asunto(s)
Varicela/diagnóstico , Varicela/virología , Brotes de Enfermedades/prevención & control , Emigración e Inmigración , Herpesvirus Humano 3/aislamiento & purificación , Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Varicela/tratamiento farmacológico , Alemania , Herpesvirus Humano 3/genética , Humanos , India , Resultado del Tratamiento
19.
J Dtsch Dermatol Ges ; 9(2): 140-3, 2011 Feb.
Artículo en Inglés, Alemán | MEDLINE | ID: mdl-20629842

RESUMEN

Only 10 cases of patients with isolated basal cell carcinoma (BCC) of the palms and soles have been published. We describe a patient with an isolated basal cell carcinoma of the palm. Our patient denied injury and exposure to noxious agents; he did not have basal cell nevus syndrome. The tumor was negative for EpCAM as determined by BerEP4 immunohistochemistry, although EpCAM expression usually is seen in BCC in more conventional locations. Because the tumor cells were connected to secretory eccrine glands, we speculate that BCC of the palm originates from common progenitor cells of eccrine glands or epidermal stem cells. We review the literature on these rare BCC in atypical anatomical regions, and discuss the cellular origin of BCC in such locations.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Carcinoma Basocelular/metabolismo , Carcinoma Basocelular/patología , Mano/patología , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología , Anciano , Carcinoma Basocelular/clasificación , Humanos , Masculino , Enfermedades Raras/clasificación , Enfermedades Raras/metabolismo , Enfermedades Raras/patología , Neoplasias Cutáneas/clasificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...